Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years

Document first published:
Page updated:
Topic:
Publication type:

This Patient Group Direction (PGD) is for the administration of Comirnaty® 10 micrograms/dose COVID-19 mRNA vaccine to children aged 5 to 11 years in accordance with the national COVID-19 vaccination programme.

This PGD is for the administration of Comirnaty® 10 micrograms/dose COVID-19 mRNA vaccine by registered healthcare practitioners identified in Section 3 of this PGD.

 

Document

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (PDF version)

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (PDF version)

  • PDF
  • 407 KB
  • 23 pages

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Updated 31 March 2022.

Document

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (Word version) - effective from 31 March 2022

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (Word version) - effective from 31 March 2022

  • Microsoft Word
  • 249 KB
  • 23 pages

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Updated 31 March 2022.